Case Report | Published:

Donor leukocyte infusions inducing remissions repeatedly in a patient with recurrent multiple myeloma after allogeneic bone marrow transplantation

Bone Marrow Transplantation volume 23, pages 195197 (1999) | Download Citation



We describe a patient with recurrent relapses after allogeneic BMT for multiple myeloma who repeatedly went into CR after donor leukocyte infusions (DLI). The first bone marrow relapse, 24 months after allogeneic BMT, was treated successfully with the infusion of 1.2 ×108 donor T cells. The second extramedullary relapse, 18 months later with a pleural mass and midthoracic spine process, responded again to DLI, however, only after three courses were given, each with escalating doses of T cells. The pleural mass was treated successfully with radiation therapy after the second DLI but reappeared 3 months later and responded again to the final DLI course with 5 × 108 T cells/kg. Nevertheless, graft-versus-host disease (GVHD) did not occur. Retrospective analysis of minimal residual disease in bone marrow aspirates during CR periods using a sensitive quantitative tumor-specific PCR showed that BM tumor cell infiltration persisted. The possible clinical implications of this case report, like maintenance DLI and the aim for molecular remissions, are discussed.

Author information


  1. Department of Hematology, University Hospital Utrecht, Utrecht, The Netherlands

    • R van der Griend
    • , LF Verdonck
    • , EJ Petersen
    • , P Veenhuizen
    •  & HM Lokhorst
  2. Department of Immunology, University Hospital Utrecht, Utrecht, The Netherlands

    • AC Bloem


  1. Search for R van der Griend in:

  2. Search for LF Verdonck in:

  3. Search for EJ Petersen in:

  4. Search for P Veenhuizen in:

  5. Search for AC Bloem in:

  6. Search for HM Lokhorst in:

Corresponding author

Correspondence to HM Lokhorst.

About this article

Publication history